Department of Obstetrics and Gynaecology, Medical College, University of Rzeszów, 35-959 Rzeszów, Poland.
Int J Mol Sci. 2022 Feb 6;23(3):1831. doi: 10.3390/ijms23031831.
Gestational diabetes mellitus (GDM) is considered a significant and increasing worldwide problem. The growing body of evidence on this topic has allowed us to point out that a hostile intrauterine environment in mothers with GDM via epigenetic mechanisms induces "diabetogenic" and "obesogenic" changes in an offspring's DNA. This sets a vicious intergenerational cycle of metabolic diseases in motion, gradually deteriorating the health of the human population. One of the most important participants of this process seems to be altered microbiota. There is a chance that the identification of specific epigenetic marks may provide a key for future diagnostic, prognostic and therapeutic solutions in the field of personalised medicine. Given the reversibility of most epigenetic changes, there is an opportunity to improve the long-term health of the human population. In this manuscript, we aim to summarise available data on epigenetic changes among women suffering from GDM and their progeny, in association with alterations in the microbiome.
妊娠期糖尿病(GDM)被认为是一个全球性的重要且日益严重的问题。关于这个主题的大量证据使我们能够指出,GDM 母亲通过表观遗传机制在子宫内为胎儿营造了一个不利于健康的环境,导致其 DNA 发生“糖尿病原性”和“肥胖原性”变化。这就引发了一种代际间代谢性疾病的恶性循环,逐渐损害人类的整体健康。在这个过程中,最重要的参与者之一似乎是改变了的微生物组。也许通过鉴定特定的表观遗传标记,可以为个性化医疗领域的未来诊断、预后和治疗提供关键信息。鉴于大多数表观遗传变化是可逆的,因此有机会改善人类的长期健康。在本文中,我们旨在总结 GDM 患者及其后代的表观遗传变化与微生物组改变相关的现有数据。